Most TN breast cancers fit within the basal-like subgroup, although these two terms are not synonymous, and immunohistochemical assessment of EGFR and basal cytokeratins 5 and 6 is usually needed for better profiling of the basal-like phenotype among the TN tumors [7]. This evidence concerns the gene EGFR and breast cancer.